These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 15681453)

  • 1. Mutational analysis of narrow pores at the fivefold symmetry axes of adeno-associated virus type 2 capsids reveals a dual role in genome packaging and activation of phospholipase A2 activity.
    Bleker S; Sonntag F; Kleinschmidt JA
    J Virol; 2005 Feb; 79(4):2528-40. PubMed ID: 15681453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of capsid conformation and Rep-capsid interactions on adeno-associated virus type 2 genome packaging.
    Bleker S; Pawlita M; Kleinschmidt JA
    J Virol; 2006 Jan; 80(2):810-20. PubMed ID: 16378983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and Biophysical Analysis of Adeno-Associated Virus Serotype 2 Capsid Assembly Variants.
    Bennett A; Gargas J; Kansol A; Lewis J; Hsi J; Hull J; Mietzsch M; Tartaglia L; Muzyczka N; Bhattacharya N; Chipman P; Agbandje-McKenna M; McKenna R
    J Virol; 2023 Jul; 97(7):e0177222. PubMed ID: 37310260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism.
    Wu P; Xiao W; Conlon T; Hughes J; Agbandje-McKenna M; Ferkol T; Flotte T; Muzyczka N
    J Virol; 2000 Sep; 74(18):8635-47. PubMed ID: 10954565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface-exposed adeno-associated virus Vp1-NLS capsid fusion protein rescues infectivity of noninfectious wild-type Vp2/Vp3 and Vp3-only capsids but not that of fivefold pore mutant virions.
    Grieger JC; Johnson JS; Gurda-Whitaker B; Agbandje-McKenna M; Samulski RJ
    J Virol; 2007 Aug; 81(15):7833-43. PubMed ID: 17507473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity.
    Girod A; Wobus CE; Zádori Z; Ried M; Leike K; Tijssen P; Kleinschmidt JA; Hallek M
    J Gen Virol; 2002 May; 83(Pt 5):973-978. PubMed ID: 11961250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface loop dynamics in adeno-associated virus capsid assembly.
    DiPrimio N; Asokan A; Govindasamy L; Agbandje-McKenna M; Samulski RJ
    J Virol; 2008 Jun; 82(11):5178-89. PubMed ID: 18367523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved Genome Packaging Efficiency of Adeno-associated Virus Vectors Using Rep Hybrids.
    Mietzsch M; Eddington C; Jose A; Hsi J; Chipman P; Henley T; Choudhry M; McKenna R; Agbandje-McKenna M
    J Virol; 2021 Sep; 95(19):e0077321. PubMed ID: 34287038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A conformational change in the adeno-associated virus type 2 capsid leads to the exposure of hidden VP1 N termini.
    Kronenberg S; Böttcher B; von der Lieth CW; Bleker S; Kleinschmidt JA
    J Virol; 2005 May; 79(9):5296-303. PubMed ID: 15827144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adeno-associated virus type 2 capsids with externalized VP1/VP2 trafficking domains are generated prior to passage through the cytoplasm and are maintained until uncoating occurs in the nucleus.
    Sonntag F; Bleker S; Leuchs B; Fischer R; Kleinschmidt JA
    J Virol; 2006 Nov; 80(22):11040-54. PubMed ID: 16956943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limitations of encapsidation of recombinant self-complementary adeno-associated viral genomes in different serotype capsids and their quantitation.
    Wang Y; Ling C; Song L; Wang L; Aslanidi GV; Tan M; Ling C; Srivastava A
    Hum Gene Ther Methods; 2012 Aug; 23(4):225-33. PubMed ID: 22966785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational changes in adeno-associated virus type 1 induced by genome packaging.
    Gerlach B; Kleinschmidt JA; Böttcher B
    J Mol Biol; 2011 Jun; 409(3):427-38. PubMed ID: 21463638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of Assembly-Activating Protein for Adeno-associated Virus Vector Production and Capsid Protein Stability in Mammalian and Insect Cells.
    Grosse S; Penaud-Budloo M; Herrmann AK; Börner K; Fakhiri J; Laketa V; Krämer C; Wiedtke E; Gunkel M; Ménard L; Ayuso E; Grimm D
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The assembly-activating protein promotes capsid assembly of different adeno-associated virus serotypes.
    Sonntag F; Köther K; Schmidt K; Weghofer M; Raupp C; Nieto K; Kuck A; Gerlach B; Böttcher B; Müller OJ; Lux K; Hörer M; Kleinschmidt JA
    J Virol; 2011 Dec; 85(23):12686-97. PubMed ID: 21917944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Capsid assembly and DNA encapsidation of adeno-associated virus].
    Wang Q; Lü Y; Li Z; Diao Y; Xu R
    Sheng Wu Gong Cheng Xue Bao; 2011 Apr; 27(4):531-8. PubMed ID: 21847986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryo-electron Microscopy Reconstruction and Stability Studies of the Wild Type and the R432A Variant of Adeno-associated Virus Type 2 Reveal that Capsid Structural Stability Is a Major Factor in Genome Packaging.
    Drouin LM; Lins B; Janssen M; Bennett A; Chipman P; McKenna R; Chen W; Muzyczka N; Cardone G; Baker TS; Agbandje-McKenna M
    J Virol; 2016 Oct; 90(19):8542-51. PubMed ID: 27440903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding.
    Opie SR; Warrington KH; Agbandje-McKenna M; Zolotukhin S; Muzyczka N
    J Virol; 2003 Jun; 77(12):6995-7006. PubMed ID: 12768018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutants at the 2-Fold Interface of Adeno-associated Virus Type 2 (AAV2) Structural Proteins Suggest a Role in Viral Transcription for AAV Capsids.
    Aydemir F; Salganik M; Resztak J; Singh J; Bennett A; Agbandje-McKenna M; Muzyczka N
    J Virol; 2016 Aug; 90(16):7196-7204. PubMed ID: 27252527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insertional mutagenesis of AAV2 capsid and the production of recombinant virus.
    Rabinowitz JE; Xiao W; Samulski RJ
    Virology; 1999 Dec; 265(2):274-85. PubMed ID: 10600599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A conserved leucine that constricts the pore through the capsid fivefold cylinder plays a central role in parvoviral infection.
    Farr GA; Tattersall P
    Virology; 2004 Jun; 323(2):243-56. PubMed ID: 15193920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.